HD-OPM Archive

Finding a good cardiologist and talking to your doctor

What the group's admins suggest about choosing a prevention-minded cardiologist, which tests are worth asking about (ApoB, hsCRP, calcium score), how to bring supplements and lifestyle changes into the conversation, and how to prepare for appointments.

15 min read42 group posts cited26 studies discussed2 chartsEvidence through Nov 2026AI Summary of posts by Louis Nervegna and Gokhan Can
Key takeaways
  • Louis Nervegna's "Rule #1" for anyone at high risk of a heart attack is to find a good cardiologist and listen to them, adding natural or alternative approaches on top of treatment rather than instead of it.
  • Doctors may not order ApoB, hsCRP, insulin or cystatin C on their own; ApoB can be ordered out of pocket, for example for about $28 through one lab company.
  • A zero calcium score or a normal coronary CT angiogram can still miss early or non-calcified plaque, so the group suggests discussing what each test can and cannot show.
  • Statin side-effect worries are worth raising openly: one group post cites the SAMSON trial as attributing about 90% of statin muscle pain to the nocebo effect, and JUPITER's 44% reduction in heart attacks and strokes over 1.9 years.
  • Doctors can legally use GRAS supplements and prescribe drugs off-label, so the best physicians can go beyond standard care while still relying on science.
  • Medication can be reduced later, together with your cardiologist, if your risk markedly improves.
In this summary
  1. Rule number one: find a good cardiologist and listen
  2. What "prevention-minded" looks like in practice
  3. Tests worth asking about
  4. Talking about medications
  5. When to see a cardiologist promptly
  6. What this means for you
  7. Frequently asked questions
  8. The evidence behind this summary

Most people in this group are not looking for a cardiologist who simply waits for symptoms. They want a doctor who treats heart disease as something that can be measured early, driven down aggressively and monitored over time. The group's admins offer a consistent answer to the question of how to find and work with such a doctor: if you are at high risk, find a good cardiologist, listen to them, and bring your own research into the conversation as additions to their plan rather than as replacements for it.1

This article pulls together what the group's posts say about choosing a doctor, which questions and tests to raise, how doctors tend to think about particular treatments, and when to see a cardiologist promptly. It is an organized summary of group discussion, not medical advice; the admins repeatedly recommend discussing any change with your own doctor.

A note on scope: the group does not publish a checklist of credentials for picking a cardiologist. What follows is built from admin opinions, personal experiences and shared expert commentary, and it is labelled as such where it is opinion.

Rule #1for anyone at high risk: find a good cardiologist and listen to them, adding other approaches on top1
$28price Louis cites for an ApoB test ordered yourself from one lab company2
70%fall in US cardiovascular deaths from the late 1960s, before progress leveled off around 20103
$100 million+minimum cost to take a new therapy through approval, sometimes nearly $1 billion4

Rule number one: find a good cardiologist and listen

Louis Nervegna, one of the group's admins, calls this "Rule #1" for people at high risk of a heart attack. His reasoning is that most of what circulates on social media is guesswork backed by little hard science, including videos that cherry-pick one study out of a hundred while ignoring the rest. Science, he says, considers the totality of the evidence.1 The group's "best of" index places this post first in its list of foundational topics.7

His second argument is about timing. In his view, people who are already at high risk have mostly lost the window to experiment; that window was years earlier, before the disease became severe. He also notes that you hear about the rare high-risk people who "cured" themselves, but not about those who experimented and died.1 This is an opinion, not a research finding, and it is worth reading as the admin's framing of risk rather than as a study result.

Add, do not replace

The practical rule that follows is simple. If you want to use alternative or natural approaches, including various diets, Louis suggests doing so in addition to what your cardiologist recommends. If those approaches work, your risk will fall and you can work with your cardiologist to reduce the amount of treatment as appropriate. He stresses there is no hard rule against stopping or reducing a medication if your condition markedly improves.1

That framing matters for the doctor relationship: you are not asking permission to abandon treatment, you are proposing a joint plan with a defined way to step treatment down if the numbers improve.

What "prevention-minded" looks like in practice

Several posts help describe what the group means by a good doctor, even though none gives a formal definition.

Science-based, but willing to go beyond the minimum

Louis explains why new therapies take so long to become standard of care: approval requires three phases (safety, preliminary efficacy and full efficacy), typically a decade or more and at least $100 million, sometimes nearly $1 billion. Large phase 3 trials often fail, so some promising therapies are never tested at that scale.4

Meanwhile, he notes, the FDA allows a physician to use any dietary supplement with GRAS status and to prescribe almost any drug off-label, such as a drug approved only for cancer being used for heart disease. This gives doctors flexibility to go beyond the standard of care. He argues the best doctors still rely on quality science when they do so, even where it does not meet the bar for full FDA approval.4

A related example is a physician quoted in a shared post who explains why he takes an SGLT2 inhibitor off-label. Louis notes that most of the evidence comes from people with diabetes and that benefits in non-diabetics are inferred from mechanisms, so this is a topic to raise with a doctor rather than assume.8

Focused on slowing the underlying processes

Louis praised one cardiologist as someone who "actually gets it" because the goal is to slow the processes that cause major diseases in the first place, which he describes as essentially the aging process, with diet as the best tool currently available, followed by exercise, lifestyle, and certain drugs and supplements.9 This is his personal view.

Aware that heart disease has many contributors

Louis summarizes a Joel Kahn video saying there are at least 25 major risk factors and that all should be addressed. LDL is special because it appears necessary for plaque formation, though not always sufficient, since some people with very high LDL never develop plaque.10 A shared video with lipidologist Tom Dayspring makes a similar point: heart disease is multifactorial, with LDL and ApoB as one major contributor alongside age, genetics, insulin resistance, chronic inflammation, endothelial dysfunction, high blood pressure, smoking and others.11 Louis also shared a graphic of 17 modifiable risk factors, noting that some are far better proven than others but that targeting as many as possible is reasonable.12

The graphic of 17 modifiable heart-disease risk factors Louis shared, from excess LDL, insulin and glucose to hypertension, elevated C-reactive protein and low vitamin D. Louis notes that some are far better proven than others.
The graphic of 17 modifiable heart-disease risk factors Louis shared, from excess LDL, insulin and glucose to hypertension, elevated C-reactive protein and low vitamin D. Louis notes that some are far better proven than others.12

The ARREST-AF trial, shared by Louis, adds a structured example: after ablation for atrial fibrillation, a physician-led risk-factor program produced 61% arrhythmia-free patients at 12 months versus 40% with usual care, in a JAMA Cardiology randomized trial.13

Treating risk factors helped ablation workShare of patients free of arrhythmia 12 months after atrial fibrillation ablation, ARREST-AF randomized trial (JAMA Cardiology)
Physician-led risk-factor program61%
Usual care40%
Source: 13
Show data
Value
Physician-led risk-factor program61%
Usual care40%

Gokhan Can, the other admin, also points listeners to lipidologists. He summarized a Peter Attia podcast episode with Tom Dayspring on atherosclerosis development, apoB and biomarkers14, and Louis shared a lipidologist's explanation of why LDL particle size probably matters little.15

The gap between guidelines and everyday care

Why does a patient sometimes have to push? One Harvard Gazette item shared by Louis says US cardiovascular deaths fell 70% from the late 1960s but leveled off around 2010, with experts citing a lack of urgency among doctors and patients and healthcare barriers.3 Gokhan says his own doctors rarely order tests such as hsCRP, ApoB, insulin and cystatin C, so he orders them himself.5

Tests worth asking about

The group's posts mention several tests that may not be ordered by default. In each case the advice is framed as something to discuss with your doctor.

TestWhat it addsCaveat from the group
ApoBCounts LDL, VLDL and IDL particles; about $28 out of pocket at one lab2Doctors may not order it by default5
hsCRPInflammation marker; ACC recommendations support universal testing16Temporarily very high during an infection17
NMR particle sizeReports small LDL particles18Adds no risk information once LDL-P is counted18
Calcium score CTMeasures calcified plaque19A zero can falsely reassure, especially younger people and women20
Coronary CT angiogramShows plaque that narrows the lumen6A normal scan can miss early plaque in the artery wall6

Lipid and inflammation markers

  • ApoB. Louis points out that ApoB tests are cheap and can be ordered yourself if a physician or insurer will not cooperate; he cites a price of $28 from one lab company. ApoB reflects LDL, VLDL and IDL particles.2
  • hsCRP. A shared cardiologist's segment described new American College of Cardiology recommendations supporting universal testing for this inflammation marker, and encouraged viewers to ask their doctor for it.16 Louis adds a timing caution: hs-CRP will be temporarily very high during an infection, so it is best not to test during that period.17
  • Particle size and ratios. Louis notes that NMR reports themselves say small LDL size is associated with risk but not once LDL-P is taken into account, which is why most cardiologists no longer order size testing.18 Gokhan shares a video on why ratios such as triglycerides:HDL-C can mislead.21
  • HDL and triglycerides. Louis argues that drugs which raise HDL have repeatedly failed to cut events in trials such as AIM-HIGH, HPS2-THRIVE, dal-OUTCOMES, ILLUMINATE and ACCELERATE.22 Likewise, in BRIDGE-TIMI 73a olezarsen cut triglycerides 64% with no change in plaque volume, and he says drug-lowering triglycerides matters little unless they exceed about 400-500 mg/dL.23 The takeaway for a doctor visit is that more numbers are not always better; ApoB already captures the risk carried by VLDL particles.23
  • Lp(a) and inflammation drugs. A shared physician commentary on two trials presented at the AHA meeting noted that one drug cut Lp(a) by nearly 80% and another sharply reduced inflammation, yet events matched placebo in both. The lesson drawn is that changing a marker does not guarantee benefit.24
  • Other markers. Louis explains that in people with low-normal ferritin and no symptoms, he believes extra iron is generally a bad idea; he advises seeing a doctor to look for sources of iron loss, with hematologists best qualified to treat true deficiency.25 He also notes that long-term very low carbohydrate diets can produce normal or low TSH with low T3 or T4, a pattern that can confuse doctors who are not used to it, so it can help to tell your doctor about your diet.26
An NMR lipoprofile report of the kind Louis discussed. The lab's own interpretive note (circled) says small LDL-P and LDL size are associated with cardiovascular risk, but not after LDL-P is taken into account.
An NMR lipoprofile report of the kind Louis discussed. The lab's own interpretive note (circled) says small LDL-P and LDL size are associated with cardiovascular risk, but not after LDL-P is taken into account.18

Imaging

A cardiologist video shared by Louis lists three tests used to evaluate heart disease: echocardiogram, cardiac stress test and calcium scoring CT.19 The group is cautious about over-reading any single result:

  • A coronary CT angiogram mainly shows plaque that narrows the lumen, so a normal scan does not rule out early plaque growing within the wall.6
  • A calcium score of zero can give false reassurance, particularly in younger people and women, according to a cardiologist's warning that Louis shared.20
  • Joel Kahn's guide to high calcium results, shared by Gokhan, covers why to get a heart CT, what to do with results and how to try to reverse atherosclerosis, and links a 2022 JACC review on plaque regression.27
  • Gokhan also summarized a video in which a presenter's calcium score fell from 66 to 42 over three years amid many simultaneous lifestyle changes; the presenter admits he does not know which mattered, and many cardiologists believe progression can be slowed but not reversed to zero.28

Risk calculators and their limits

Louis shared the AHA's PREVENT calculator for ages 30 to 79 without known cardiovascular disease, built on newer and more diverse data than the 2013 Pooled Cohort Equations and including kidney and metabolic conditions. He warns it will underestimate risk if you already had a heart attack or stroke, have significant atherosclerosis or a high calcium score.29 In another post he compares hazard ratios from the SCORE O.P. model for people over 65: age compounds to roughly 19.5 times higher coronary death risk from 65 to 85, compared with 2.3 times for diabetes and 1.88 for smoking.30 This is a useful reminder to ask your doctor which calculator they use and what it leaves out.

After 65, age dwarfs the other risk factorsHow much each factor multiplies the risk of dying from coronary heart disease in the SCORE O.P. model for people over 65, as Louis calculated from the table (figures for women)
*Aging from 65 to 8519.5
Diabetes2.3
Smoking1.88
Systolic blood pressure 40 mmHg higher1.31
Total cholesterol 40 mg/dL (1 mmol/L) higher1.13
The age figure compounds a hazard ratio of 1.16 per year over 20 years, and the blood pressure figure compounds 1.07 per 10 mmHg; these are Louis's calculations. Figures for men are similar. Source: 30
Show data
Times higher risk (log scale)95% CI
*Aging from 65 to 8519.5–
Diabetes2.3–
Smoking1.88–
Systolic blood pressure 40 mmHg higher1.31–
Total cholesterol 40 mg/dL (1 mmol/L) higher1.13–

Talking about medications

Medication conversations are where many people feel stuck, and the group has several examples of how to approach them.

Statins: raise the worries openly

Louis wrote a point-by-point summary of what a cardiologist at a major research hospital would likely say about statins. He cites a meta-analysis of 55 studies in over 7 million people linking statin use to lower dementia risk, and the SAMSON trial, which he says showed about 90% of statin muscle pain is attributable to the nocebo effect (symptoms driven by expectation of harm). He also cites JUPITER, in which statins lowered heart attacks and strokes by 44% versus placebo in 1.9 years, and a pooled analysis of 13 trials (91,140 patients) in which 255 people treated for 4 years produced one extra diabetes case while preventing 5.4 cardiovascular events.31

On benefit, he shares a Cleveland Clinic cardiologist's explanation that statins can reverse plaque when LDL is pushed below 70 mg/dL, mainly by shrinking the fatty core, and that six large trials showed total plaque volume falling 5% to 17%.32

A real example of a detailed conversation

Gokhan posted the message he sent his cardiologist. On rosuvastatin 5 mg plus ezetimibe 10 mg his LDL was 90 and then 63 mg/dL, similar to earlier values on low-dose rosuvastatin alone (71, 70, 91). He had also noticed his fasting insulin rise from about 14 to about 21 uIU/mL, and asked about pitavastatin plus an injectable PCSK9 inhibitor.33 It is a single person's data (an n-of-1), but it shows a useful pattern: bring your numbers, state your specific concern, and propose options to discuss.

In another post he describes reconsidering his target after a friend had a heart attack at 48. At an LDL of 70 mg/dL he was thinking about retrying low-dose ezetimibe to approach 50 mg/dL, with his cardiologist's support.34

Niacin and other add-ons

Louis explains that niacin can lower Lp(a) and is still used by some cardiologists; one member saw a 40% drop on 1500 mg. But niacin has not been proven in large trials to reduce heart attacks, strokes or mortality, and two very large trials found no extra benefit on top of high-dose statins with more side effects. He frames it as something to discuss with your cardiologist, not a substitute for proven drugs.35 In a later post he repeats that Lp(a) falls as much as 80% have been reported but are uncommon, and that niacin should not be combined with high-dose statins.36

Aspirin during infections

Louis notes that infections temporarily raise the risk of heart attack and stroke, and suggests people with heart disease ask their doctor about a daily baby aspirin during illness and for a period afterward.37 He gives a window of about a week or two after the infection or vaccination, if the doctor approves.17 For Covid, he cites a 2022 meta-analysis associating aspirin with lower mortality without more bleeding.38

When to see a cardiologist promptly

A post sharing Mayo Clinic and Cleveland Clinic information notes that atrial fibrillation is the most common type of tachycardia and that ischemic heart disease from atherosclerotic blockages is the most common cause of ventricular tachycardia; Louis advises seeing a cardiologist as soon as possible if rapid heartbeat occurs.39 A post Louis shared on isometric wall squats for blood pressure adds that people with heart disease should consult a doctor first and never hold their breath during the holds.40

In one reported case, a sitosterolemia essay describes a person with clogged arteries despite good health, and Louis notes that it may be more common than doctors realize. This is a reminder that unexplained disease may deserve further workup.41

What this means for you

These points are drawn from admin opinion and shared material; check them with your own doctor.

  • If you are at high risk, the group's admins recommend finding a cardiologist you trust and following the plan, adding other approaches rather than replacing treatment.1
  • Consider asking whether ApoB, hsCRP and other markers have been measured, and note that some can be ordered yourself.2516
  • Ask what a scan can and cannot rule out before drawing reassurance from a normal CTA or a zero calcium score.620
  • Bring up statin worries, supplements and diet changes, and discuss a plan to scale treatment down if your numbers improve.131
  • Ask which risk calculator is used and whether it fits your situation, especially if you already have plaque.29
  • Avoid blood tests for inflammation while sick, and ask about aspirin during infections.17
  • Tell your doctor about unusual diets, since patterns such as low T3 on very low carbohydrate diets may be missed.26
  • Treat supplements and off-label ideas as topics for a science-minded doctor, not self-prescription.4

Frequently asked questions

What if my doctor does not order the tests I want?

Gokhan reports that his doctors rarely order hsCRP, ApoB, insulin or cystatin C, so he orders them himself.5 Louis notes ApoB is inexpensive and can be paid for out of pocket.2 Share results with your doctor afterward.

Should I try alternative approaches instead of medication?

Louis's advice for high-risk people is to add them to, not substitute them for, cardiologist-recommended treatment, and to reduce treatment later with your doctor if risk falls.1

Can a good doctor go beyond guidelines?

According to Louis, yes: physicians can use GRAS supplements and prescribe off-label, and the best ones still base this on quality science.4

Is a zero calcium score or normal CT angiogram enough?

Not necessarily. A normal CTA can miss early wall plaque, and a zero calcium score can falsely reassure, particularly in younger people and women.620

Are statins safe to discuss with my cardiologist?

Louis's summary cites evidence on dementia, muscle pain and diabetes risk, and notes the very low cost of generic statins, for example a one-month supply of 5 mg rosuvastatin for $4 on Amazon pharmacy.31 If you have side effects, raise them openly; Gokhan's own message shows how to present data and options.33

Is there a book I can bring to my cardiologist?

Louis recommends "The Stents I Didn't Get" by group member Steve Kaplan, saying it is consistent with what the group recommends and suggesting readers give a copy to their cardiologist. Proceeds go to heart-disease charities.42

The evidence behind this summary26 studies · 4 meta-analyses · 11 trials · 2 observational

The 42 group posts cited above discuss 26 studies and sources. Their mix of study designs shows how much rests on randomized trials and meta-analyses, which can show cause and effect, and how much on observational, lab or animal work, which mostly cannot.

Meta-analyses 4Randomized trials 11Observational studies 2Reviews & guidelines 2Other sources 7

Strongest evidence discussed

All 26 studies and sources
Sources from the group (42)
  1. At high risk of a heart attack? Find a good cardiologist and add, don't replace, treatment Louis Nervegna · Feb 26, 2024 · Facebook
  2. ApoB tests are cheap, about $28 if ordered yourself Louis Nervegna · Feb 22, 2024 · Facebook
  3. Harvard: decline in US cardiovascular deaths stalled around 2010 Louis Nervegna · May 23, 2025 · Facebook
  4. Why new therapies take 10+ years and $100M+ for FDA approval, and what doctors can do Louis Nervegna · Jan 15, 2024 · Facebook
  5. Ordering hsCRP, ApoB, insulin and cystatin C yourself when doctors do not Gokhan Can · Jul 05, 2025 · Facebook
  6. A normal coronary CTA can still miss early wall plaque that has not narrowed the lumen Louis Nervegna · Jul 25, 2024 · Facebook
  7. Best of the group: an index of key posts on LDL, risk and plaque reversal Gokhan Can · Mar 23, 2024 · Facebook
  8. SGLT2 inhibitors may offer benefits beyond diabetes, argues Dr. Lawenda Louis Nervegna · Mar 05, 2025 · Facebook
  9. Cardiologist emphasis on slowing aging as the root of disease Louis Nervegna · Nov 02, 2025 · Facebook
  10. LDL is necessary but not always sufficient for atherosclerosis, among 25+ risk factors Louis Nervegna · Mar 25, 2024 · Facebook
  11. Some with high LDL avoid plaque, but heart disease is multifactorial and most aren't lucky Louis Nervegna · Jun 19, 2026 · Facebook
  12. Seventeen modifiable heart-disease risk factors: target as many as possible Louis Nervegna · Nov 23, 2023 · Facebook
  13. ARREST-AF: risk-factor program improved ablation outcomes (61% vs 40% arrhythmia-free) Louis Nervegna · Jan 05, 2026 · Facebook
  14. Tom Dayspring on atherosclerosis development, apoB and biomarkers (The Drive #334) Gokhan Can · Feb 04, 2025 · Facebook
  15. LDL particle size probably matters little once confounding and particle number are counted Louis Nervegna · Jun 16, 2024 · Facebook
  16. ACC recommends broader hsCRP testing to detect low-grade inflammation Louis Nervegna · Oct 05, 2025 · Facebook
  17. Infections temporarily raise heart attack and stroke risk; vaccines may do so far less Louis Nervegna · Oct 14, 2024 · Facebook
  18. NMR LDL particle size adds no risk information once LDL-P or ApoB is known Louis Nervegna · Apr 30, 2026 · Facebook
  19. Three tests for heart disease: echocardiogram, stress test and calcium score CT Louis Nervegna · Jul 14, 2024 · Facebook
  20. A CAC score of zero can give false reassurance, especially in younger people and women Louis Nervegna · Feb 04, 2026 · Facebook
  21. Why low LDL-C correlates with higher mortality: causation versus correlation Gokhan Can · Nov 17, 2023 · Facebook
  22. Drugs that raise HDL have repeatedly failed to cut cardiovascular events Louis Nervegna · Jun 12, 2026 · Facebook
  23. Lowering triglycerides alone does not shrink plaque: olezarsen cut TG 64%, plaque flat Louis Nervegna · May 20, 2026 · Facebook
  24. Pelacarsen and ziltivekimab lowered their targets but not events, and why that matters Louis Nervegna · Nov 08, 2026 · Facebook
  25. Should you take iron for low-normal ferritin? Probably not without symptoms or a cause Louis Nervegna · Mar 21, 2026 · Facebook
  26. Prolonged very low carb diets can suppress thyroid hormones while TSH looks normal Louis Nervegna · Oct 13, 2025 · Facebook
  27. What to do with a high coronary calcium CT result: Joel Kahn's guide Gokhan Can · Nov 17, 2023 · Facebook
  28. Tom Seest's CAC drop from 66 to 42 over three years, and the debate about reversal Gokhan Can · Dec 02, 2023 · Facebook
  29. AHA PREVENT calculator replaces Pooled Cohort Equations for ages 30-79 Louis Nervegna · Jan 25, 2024 · Facebook
  30. Age raises CVD death risk about 19.5x from 65 to 85, far above diabetes or smoking Louis Nervegna · Dec 18, 2023 · Facebook
  31. What cardiologists say about statins: dementia, muscle pain, diabetes, primary prevention Louis Nervegna · Jan 13, 2026 · Facebook
  32. Statins reverse total and soft plaque once LDL is below 70 mg/dL, Cleveland Clinic says Louis Nervegna · Sep 04, 2025 · Facebook
  33. Admin asks cardiologist about rosuvastatin raising insulin, and pitavastatin plus PCSK9i Gokhan Can · Dec 30, 2025 · Facebook
  34. Friend's heart attack at 48 prompts reconsideration of LDL 70 and low-dose ezetimibe Gokhan Can · Sep 07, 2025 · Facebook
  35. Niacin can cut Lp(a) (one member saw 40% with 1500 mg) but has no outcome proof Louis Nervegna · Jan 19, 2024 · Facebook
  36. Niacin has lowered Lp(a) up to 80% in rare cases but is a long shot Louis Nervegna · Aug 13, 2025 · Facebook
  37. Flu and respiratory infections raise heart attack risk; ask your doctor about baby aspirin Louis Nervegna · Sep 11, 2024 · Facebook
  38. Baby aspirin during and after Covid may be worth discussing if you have heart disease Louis Nervegna · Jan 06, 2024 · Facebook
  39. Rapid heartbeat is most often AFib, but coronary blockage is another common cause Louis Nervegna · Mar 09, 2025 · Facebook
  40. Wall squat isometric holds may lower systolic blood pressure about 9 points in weeks Louis Nervegna · Nov 04, 2026 · Facebook
  41. Sitosterolemia may be more common than doctors realize, WSJ essay says Louis Nervegna · Nov 24, 2024 · Facebook
  42. Book recommendation: 'The Stents I Didn't Get' by group member Steve Kaplan Louis Nervegna · Nov 12, 2026 · Facebook

Keep exploring

Related research summaries

Topics and hashtags in this summary